LONDON – Final results of the community pilot in Liverpool, U.K., that used the controversial Innova Medical Group Inc. lateral flow device to test all comers for COVID-19, show new cases fell by 21% ...
The proportion of COVID-19 infections missed by the Innova lateral flow test (LFT) are “substantial enough to be of clinical importance” according to an analysis published in The BMJ. The study by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback